10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0001144204-16-117596`
Period End Date	20160630
Filing Date	20160809
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	lbio-20160630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 50 Income Statement 36 Cash Flow Statement 52 Stockholders Equity 20 Comprehensive Income 12

Balance Sheet 50 line items

Line Item	Tag	Value	Unit	Period
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.64K	USD	Point-in-time
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.10K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$44.91M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.64M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.56M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$101.22M	USD	Point-in-time
Money market funds	`MoneyMarketFundsAtCarryingValue`	$19.95M	USD	Point-in-time
Money market funds	`MoneyMarketFundsAtCarryingValue`	$19.74M	USD	Point-in-time
Short-term investments available for sale	`AvailableForSaleSecuritiesCurrent`	$70.11M	USD	Point-in-time
Short-term investments available for sale	`AvailableForSaleSecuritiesCurrent`	$70.60M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$782.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$277.00K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$103.98M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$192.35M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Property and equipment, net of accumulated depreciation and amortization of $1,643 and $1,103, respectively	`PropertyPlantAndEquipmentNet`	$1.19M	USD	Point-in-time
Property and equipment, net of accumulated depreciation and amortization of $1,643 and $1,103, respectively	`PropertyPlantAndEquipmentNet`	$1.68M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Total Assets	`Assets`	$105.65M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Total Assets	`Assets`	$193.54M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	58.39M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	48.55M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$725.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$958.00K	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	48.55M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	58.39M	shares	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$672.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.88M	USD	Point-in-time
Common Stock To Be Issued Shares	`CommonStockToBeIssuedShares`	303,125.00	shares	Point-in-time
Common Stock To Be Issued Shares	`CommonStockToBeIssuedShares`	303,125.00	shares	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$4.61M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.63M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized, 58,388,905 and 48,547,720 shares issued and outstanding, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized, 58,388,905 and 48,547,720 shares issued and outstanding, respectively	`CommonStockValue`	$2.00K	USD	Point-in-time
Common stock to be issued, 303,125 shares	`CommonStockToBeIssuedValue`	$245.00K	USD	Point-in-time
Common stock to be issued, 303,125 shares	`CommonStockToBeIssuedValue`	$245.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$48.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$78.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$207.95M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$311.27M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-122.67M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-104.22M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$188.94M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$104.02M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$193.54M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$105.65M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	-	USD	1 Quarter
Revenues	`Revenues`	-	USD	2 Qtrs
Revenues	`Revenues`	-	USD	1 Quarter
Revenues	`Revenues`	-	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$6.84M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.05M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.46M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$8.65M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$4.90M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$7.26M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$10.08M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.38M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$11.74M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$6.44M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$11.73M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$18.74M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-11.73M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-11.74M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-6.44M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-18.74M	USD	2 Qtrs
Interest income	`InterestIncomeExpenseNet`	$73.00K	USD	2 Qtrs
Interest income	`InterestIncomeExpenseNet`	$290.00K	USD	2 Qtrs
Interest income	`InterestIncomeExpenseNet`	$73.00K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$164.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-18.45M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-11.56M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-6.37M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-11.66M	USD	2 Qtrs
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.37	USD	2 Qtrs
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.14	USD	1 Quarter
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.23	USD	1 Quarter
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.28	USD	2 Qtrs
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	49.81M	shares	2 Qtrs
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	45.08M	shares	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	41.41M	shares	2 Qtrs
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	51.08M	shares	1 Quarter

Cash Flow Statement 52 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-18.45M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-11.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.37M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.66M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$425.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$540.00K	USD	2 Qtrs
Fair value of vested stock options	`StockOptionPlanExpense`	$6.07M	USD	2 Qtrs
Fair value of vested stock options	`StockOptionPlanExpense`	$2.30M	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.09M	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.07M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$312.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$505.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$2.98M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$204.00K	USD	2 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-7.96M	USD	2 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-8.30M	USD	2 Qtrs
Liquidation (Purchase) of money market funds	`PaymentsForProceedsFromShortTermInvestments`	$7.48M	USD	2 Qtrs
Liquidation (Purchase) of money market funds	`PaymentsForProceedsFromShortTermInvestments`	$-201.00K	USD	2 Qtrs
Purchase of short- term investments	`PaymentsToAcquireAvailableForSaleSecurities`	$96.28M	USD	2 Qtrs
Purchase of short- term investments	`PaymentsToAcquireAvailableForSaleSecurities`	$68.34M	USD	2 Qtrs
Maturities of short- term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$4.00M	USD	2 Qtrs
Maturities of short- term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$67.88M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$919.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$56.00K	USD	2 Qtrs
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-100.68M	USD	2 Qtrs
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-314.00K	USD	2 Qtrs
Tax payments related to shares withheld for vested restricted stock units	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$349.00K	USD	2 Qtrs
Tax payments related to shares withheld for vested restricted stock units	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of warrants	`ProceedsFromWarrantExercises`	$621.00K	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of warrants	`ProceedsFromWarrantExercises`	$7.97M	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$237.00K	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Proceeds from the issuance of preferred and common stock, net	`ProceedsFromIssuanceOrSaleOfEquity`	$95.69M	USD	2 Qtrs
Proceeds from the issuance of preferred and common stock, net	`ProceedsFromIssuanceOrSaleOfEquity`	$68.31M	USD	2 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$96.19M	USD	2 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$76.28M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-32.35M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$87.58M	USD	2 Qtrs
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$44.91M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$13.64M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$12.56M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$101.22M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$44.91M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$13.64M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$12.56M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$101.22M	USD	Point-in-time
Interest	`InterestPaid`	-	USD	2 Qtrs
Interest	`InterestPaid`	-	USD	2 Qtrs
Taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherSignificantNoncashTransactionValueOfConsiderationReceived1`	$30.00K	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherSignificantNoncashTransactionValueOfConsiderationReceived1`	$22.00K	USD	2 Qtrs

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$188.94M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$104.02M	USD	Point-in-time
Fair value of vested stock options	`AdjustmentsToAdditionalPaidInCapitalMarkToMarket`	$6.07M	USD	2 Qtrs
Vesting of restricted shares issued for services	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition`	$1.07M	USD	2 Qtrs
Tax payments related to shares witheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-349.00K	USD	2 Qtrs
Common stock issued upon exercise of warrants	`CommonStockIssuedUponExerciseOfWarrantsAmount`	$621.00K	USD	2 Qtrs
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$237.00K	USD	2 Qtrs
Common stock sold in private placement, net of offering costs	`StockIssuedDuringPeriodValueOther`	$44.01M	USD	2 Qtrs
Preferred stock sold in private placement, net of offering costs	`Preferredstocksoldinprivateplacementvalue`	$51.68M	USD	2 Qtrs
Cancellation of restricted shares issued for services	`StockCancelledDuringPeriodRestrictedSharesValue`	-	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$30.00K	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$22.00K	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$22.00K	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$10.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-18.45M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-11.56M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-6.37M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-11.66M	USD	2 Qtrs
Ending Balance	`StockholdersEquity`	$188.94M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$104.02M	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-18.45M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-11.56M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-6.37M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-11.66M	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$30.00K	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$22.00K	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$22.00K	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$10.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-18.42M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-11.64M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-6.34M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-11.55M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.